YZ-002(YZ-002) - 在研适应症：自身免疫性疾病_专利_临床

概要

基本信息

药物类型

小分子化药

别名

靶点-

作用机制-

治疗领域

免疫系统疾病

在研适应症

自身免疫性疾病

非在研适应症-

原研机构

广东银珠医药科技有限公司

在研机构

广东银珠医药科技有限公司

非在研机构-

最高研发阶段临床1期

首次获批日期-

最高研发阶段(中国)临床1期

特殊审评-

登录后查看时间轴

关联

100 项与 YZ-002 相关的临床结果

登录后查看更多信息

100 项与 YZ-002 相关的转化医学

登录后查看更多信息

100 项与 YZ-002 相关的专利（医药）

登录后查看更多信息

2

项与 YZ-002 相关的文献（医药）

2006-03-01·Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology

[Bioinformatics analysis of YZ-2 and preparation of polyclonal antibody].

Article

作者: Yan, Guang-mei ; Zang, Lin-quan ; Xiao, Ru ; Qiu, Peng-xin

AIMTo analyze YZ-2, a novel protein associated with cerebral ischemia and prepares its polyclonal antibody.METHODSAccording to the bioinformatics analysis and prediction of the possible high structure, hydrophilicity and antigenicity of YZ-2, a 22-amino acid residue partial peptide of YZ-2 was synthesized. The synthesized peptide was then used to immunize. And the properties of anti-YZ2 were analyzed by ELISA and Western blot.RESULTSThe hydrophilicity and antigenicity were predicted by methods of bioinformatics. The polyclonal antibody of YZ-2 was successfully obtained and its specificity and sensitivity were conformed by ELISA and Western blot.CONCLUSIONBy the bioinformatics analysis and prediction, the hydrophilicity and antigenicity of YZ2 were analyzed. The antibody of YZ-2 was successfully obtained.

RSC Advances3区 · 化学

Optimization and characterization of biosurfactant produced by indigenous Brevibacillus borstelensis isolated from a low permeability reservoir for application in MEOR

3区 · 化学

ArticleOA

作者: Li, Yang ; She, Yuehui ; Wang, Xiaotong ; Gu, Yongan ; He, Yanlong ; Dong, Hao ; Banat, I. M. ; Zheng, Anying ; Yu, Gaoming ; Sun, Shanshan ; Zhang, Fan

Biosurfactants are expected to be a key factor for microbial enhanced oil recovery (MEOR).

100 项与 YZ-002 相关的药物交易

登录后查看更多信息